ARTBIO
Radiopharmaceutical Oncology
2 open roles Radiopharmaceutical Oncology Cambridge, United States 74 employees $245M raised Est. 2021
F-Prime Capital
Omega Funds
Radforsk
Third Rock Ventures
Sofinnova Investments
B Capital
About ARTBIO
ARTBIO is a clinical-stage radiopharmaceutical company developing a new class of alpha radioligand therapies (ARTs) to redefine cancer care.
ARTBIO is listed on Rocketlist with 2 active roles. The company is categorized as Radiopharmaceutical Oncology in BioTech. ARTBIO is at Series B stage, with a B2B business model, headquartered in Cambridge, United States. ARTBIO was founded in 2021 and has 74 employees. ARTBIO has raised $245M. Active roles are refreshed daily from public hiring sources.